U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 39

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr16:2096293
GRCh38:
Chr16:2046292
NTHL1D64YFamilial adenomatous polyposis 3Uncertain significance
(Sep 24, 2022)
criteria provided, single submitter
2.
GRCh37:
Chr16:2096298
GRCh38:
Chr16:2046297
NTHL1A3fs, G62fsFamilial adenomatous polyposis 3Pathogenic
(Jan 19, 2023)
criteria provided, single submitter
3.
GRCh37:
Chr16:2096284
GRCh38:
Chr16:2046283
NTHL1K67*, R7SFamilial adenomatous polyposis 3Pathogenic
(Jan 19, 2023)
criteria provided, single submitter
4.
GRCh37:
Chr16:2093639
GRCh38:
Chr16:2043638
NTHL1A95E, A148E, A205EFamilial adenomatous polyposis 3, not provided, Hereditary cancer-predisposing syndrome
Uncertain significance
(Mar 22, 2022)
criteria provided, multiple submitters, no conflicts
5.
GRCh37:
Chr16:2090180
GRCh38:
Chr16:2040179
NTHL1K139*, K192*, K249*Familial adenomatous polyposis 3Likely pathogenic
(May 3, 2021)
criteria provided, single submitter
6.
GRCh37:
Chr16:2090189
GRCh38:
Chr16:2040188
NTHL1K136*, K189*, K246*Familial adenomatous polyposis 3, not providedPathogenic
(Mar 1, 2023)
criteria provided, multiple submitters, no conflicts
7.
GRCh37:
Chr16:2097731
GRCh38:
Chr16:2047730
NTHL1R32WFamilial adenomatous polyposis 3, Hereditary cancer-predisposing syndrome, not provided
Uncertain significance
(Oct 14, 2021)
criteria provided, multiple submitters, no conflicts
8.
GRCh37:
Chr16:2096242
GRCh38:
Chr16:2046241
NTHL1P81AFamilial adenomatous polyposis 3, Hereditary cancer-predisposing syndrome, not provided
Uncertain significance
(Nov 30, 2022)
criteria provided, multiple submitters, no conflicts
9.
GRCh37:
Chr16:2093592
GRCh38:
Chr16:2043591
NTHL1A111T, A164T, A221TFamilial adenomatous polyposis 3, Hereditary cancer-predisposing syndromeUncertain significance
(May 21, 2022)
criteria provided, multiple submitters, no conflicts
10.
GRCh37:
Chr16:2096376
GRCh38:
Chr16:2046375
NTHL1Familial adenomatous polyposis 3, not providedUncertain significance
(Jan 26, 2022)
criteria provided, multiple submitters, no conflicts
11.
GRCh37:
Chr16:2093580
GRCh38:
Chr16:2043579
NTHL1V115M, V168M, V225Mnot provided, Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 3
Uncertain significance
(Apr 27, 2023)
criteria provided, multiple submitters, no conflicts
12.
GRCh37:
Chr16:2096134
GRCh38:
Chr16:2046133
NTHL1P117Tnot specified, not provided, Hereditary cancer-predisposing syndrome,
Familial adenomatous polyposis 3
Uncertain significance
(Aug 15, 2023)
criteria provided, multiple submitters, no conflicts
13.
GRCh37:
Chr16:2096377
GRCh38:
Chr16:2046376
NTHL1Familial adenomatous polyposis 3, not specified, not provided
Benign/Likely benign
(Aug 15, 2023)
criteria provided, multiple submitters, no conflicts
14.
GRCh37:
Chr16:2097701
GRCh38:
Chr16:2047700
NTHL1Familial adenomatous polyposis 3, not providedLikely benign
(Aug 19, 2022)
criteria provided, multiple submitters, no conflicts
15.
GRCh37:
Chr16:2093728
GRCh38:
Chr16:2043727
NTHL1Familial adenomatous polyposis 3, Hereditary cancer-predisposing syndrome, not provided
Pathogenic/Likely pathogenic
(Feb 17, 2023)
criteria provided, multiple submitters, no conflicts
16.
GRCh37:
Chr16:2097794
GRCh38:
Chr16:2047793
NTHL1R11WFamilial adenomatous polyposis 3, Hereditary cancer-predisposing syndrome, not provided
Uncertain significance
(Feb 17, 2023)
criteria provided, multiple submitters, no conflicts
17.
GRCh37:
Chr16:2094711
GRCh38:
Chr16:2044710
NTHL1R149W, R39Wnot provided, Hereditary cancer-predisposing syndromeUncertain significance
(May 8, 2023)
criteria provided, multiple submitters, no conflicts
18.
GRCh37:
Chr16:2097805
GRCh38:
Chr16:2047804
NTHL1R7TFamilial adenomatous polyposis 3, Hereditary cancer-predisposing syndrome, not provided
Uncertain significance
(Feb 9, 2023)
criteria provided, multiple submitters, no conflicts
19.
GRCh37:
Chr16:2097779
GRCh38:
Chr16:2047778
NTHL1G16Rnot provided, Familial adenomatous polyposis 3, Hereditary cancer-predisposing syndrome
Uncertain significance
(Sep 14, 2022)
criteria provided, multiple submitters, no conflicts
20.
GRCh37:
Chr16:2093676
GRCh38:
Chr16:2043675
NTHL1G83S, G193S, G136SFamilial adenomatous polyposis 3, Hereditary cancer-predisposing syndrome, not provided,
not specified
Uncertain significance
(Aug 15, 2023)
criteria provided, multiple submitters, no conflicts
21.
GRCh37:
Chr16:2094798
GRCh38:
Chr16:2044797
NTHL1R10G, R120GFamilial adenomatous polyposis 3, Hereditary cancer-predisposing syndrome, not provided
Uncertain significance
(Feb 10, 2023)
criteria provided, multiple submitters, no conflicts
22.
GRCh37:
Chr16:2090179
GRCh38:
Chr16:2040178
NTHL1K192R, K139R, K249RFamilial adenomatous polyposis 3, Hereditary cancer-predisposing syndrome, not provided,
not specified
Uncertain significance
(Aug 15, 2023)
criteria provided, multiple submitters, no conflicts
23.
GRCh37:
Chr16:2090162
GRCh38:
Chr16:2040161
NTHL1R198C, R255C, R145CFamilial adenomatous polyposis 3, Hereditary cancer-predisposing syndrome, not provided
Uncertain significance
(Oct 27, 2022)
criteria provided, multiple submitters, no conflicts
24.
GRCh37:
Chr16:2097709
GRCh38:
Chr16:2047708
NTHL1not provided, Familial adenomatous polyposis 3, Hereditary cancer-predisposing syndrome
Pathogenic/Likely pathogenic
(Jul 18, 2023)
criteria provided, multiple submitters, no conflicts
25.
GRCh37:
Chr16:2090156
GRCh38:
Chr16:2040155
NTHL1A200T, A147T, A257TFamilial adenomatous polyposis 3, not specified, Hereditary cancer-predisposing syndrome,
not provided
Conflicting interpretations of pathogenicity
(Aug 15, 2023)
criteria provided, conflicting interpretations
26.
GRCh37:
Chr16:2097720
GRCh38:
Chr16:2047719
NTHL1E35DFamilial adenomatous polyposis 3, not providedUncertain significance
(May 31, 2023)
criteria provided, multiple submitters, no conflicts
27.
GRCh37:
Chr16:2094701
GRCh38:
Chr16:2044700
NTHL1T42K, T152KFamilial adenomatous polyposis 3, Hereditary cancer-predisposing syndrome, not provided
Uncertain significance
(Nov 1, 2022)
criteria provided, multiple submitters, no conflicts
28.
GRCh37:
Chr16:2093633
GRCh38:
Chr16:2043632
NTHL1P150L, P207L, P97LFamilial adenomatous polyposis 3, Hereditary cancer-predisposing syndrome, not provided
Uncertain significance
(Aug 17, 2023)
criteria provided, multiple submitters, no conflicts
29.
GRCh37:
Chr16:2093573
GRCh38:
Chr16:2043572
NTHL1G227D, G170D, G117Dnot provided, not specified, Hereditary cancer-predisposing syndrome
Uncertain significance
(Nov 2, 2022)
criteria provided, multiple submitters, no conflicts
30.
GRCh37:
Chr16:2097818
GRCh38:
Chr16:2047817
NTHL1A3SFamilial adenomatous polyposis 3, not provided, Hereditary cancer-predisposing syndrome
Uncertain significance
(Jul 6, 2022)
criteria provided, multiple submitters, no conflicts
31.
GRCh37:
Chr16:2096334
GRCh38:
Chr16:2046333
NTHL1P50LHereditary cancer-predisposing syndrome, not providedUncertain significance
(Feb 5, 2023)
criteria provided, multiple submitters, no conflicts
32.
GRCh37:
Chr16:2090143
GRCh38:
Chr16:2040142
NTHL1W151*, W204*, W261*not provided, Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 3
Likely pathogenic
(Jun 5, 2023)
criteria provided, multiple submitters, no conflicts
33.
GRCh37:
Chr16:2090005
GRCh38:
Chr16:2040004
NTHL1Q279*, Q222*, Q169*Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 3, not provided
Pathogenic/Likely pathogenic
(Aug 15, 2023)
criteria provided, multiple submitters, no conflicts
34.
GRCh37:
Chr16:2090008
GRCh38:
Chr16:2040007
NTHL1G278S, G168S, G221Snot provided, Familial adenomatous polyposis 3, Hereditary cancer-predisposing syndrome
Uncertain significance
(Mar 9, 2023)
criteria provided, multiple submitters, no conflicts
35.
GRCh37:
Chr16:2094653
GRCh38:
Chr16:2044652
NTHL1I168T, I58THereditary cancer-predisposing syndrome, not specified, Familial adenomatous polyposis 3,
not provided
Conflicting interpretations of pathogenicity
(Aug 15, 2023)
criteria provided, conflicting interpretations
36.
GRCh37:
Chr16:2096271-2096272
GRCh38:
Chr16:2046270-2046271
NTHL1A71fsnot provided, Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 3
Pathogenic/Likely pathogenic
(Oct 22, 2022)
criteria provided, multiple submitters, no conflicts
37.
GRCh37:
Chr16:2096209
GRCh38:
Chr16:2046208
NTHL1R92CFamilial adenomatous polyposis 3, not provided, Hereditary cancer-predisposing syndrome,
not specified
Conflicting interpretations of pathogenicity
(Aug 15, 2023)
criteria provided, conflicting interpretations
38.
GRCh37:
Chr16:2093567
GRCh38:
Chr16:2043566
NTHL1Familial adenomatous polyposis 3, not providedPathogenic/Likely pathogenic
(Feb 11, 2022)
criteria provided, multiple submitters, no conflicts
39.
GRCh37:
Chr16:2096239
GRCh38:
Chr16:2046238
NTHL1Q82*Familial adenomatous polyposis 3, not provided, Hereditary cancer-predisposing syndrome
Conflicting interpretations of pathogenicity
(Aug 15, 2023)
criteria provided, conflicting interpretations
Format
Items per page
Sort by
Choose Destination